Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 HKD | -3.55% | +31.56% | -9.27% |
Jun. 04 | Akeso Expands Territory of License Agreement for Lung Cancer Drug | MT |
Jun. 03 | Summit Therapeutics Inc. Expands License Territories for Ivonescimab | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
4.9B | - | |||||
123B | ||||||
107B | ||||||
24.01B | - | |||||
22.59B | - | |||||
18.16B |
- Stock Market
- Equities
- 9926 Stock
- Charts Akeso, Inc.
- Sector Chart